Home › Colite ulcerosa › New York › New York City
Studi clinici su Colite ulcerosa a New York City, NY
23 studi su Colite ulcerosa cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
In reclutamentoFase 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
In reclutamentoFase 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 2
- Pioneer Clinical Research NY, New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
In reclutamentoFase 4
- New York Gastroenterology Associates, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
In reclutamentoFase 2
- Site 037, New York
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical College, New York
- e altri 2
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
In reclutamentoFase 2/3
- Columbia University Medical Center, New York
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
In reclutamentoFase 3
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
In reclutamentoFase 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
In reclutamentoFase 4
- NYU Langone Health, New York
- Weill Cornell Medical College- New York Presbyterian Hospital, New York
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- New York Gastroenterology Associates - Site Number: 8400009, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- New York Gastroenterology Associates, New York
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
In reclutamentoFase 2
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- e altri 4
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
In reclutamentoFase 2
- Columbia University Medical Center, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- Weill Cornell Medical College - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- e altri 2
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
In reclutamento
- NYU Langone Health, New York
- Cornell University, New York
BOOM-IBD2 Pivotal Clinical Trial
In reclutamento
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
In reclutamentoStudio osservazionale
- New York University, New York
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
In reclutamentoStudio osservazionale
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
In reclutamentoFase 3
- New York Presbyterian Hospital, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
In reclutamentoFase 2
- Mirador Therapeutics Selected Site, New York
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
In reclutamentoStudio osservazionale
- New York University, New York
Studi su Colite ulcerosa in altre città
- Orlando, FL22 studi
- Miami, FL21 studi
- Houston, TX17 studi
- San Antonio, TX16 studi
- Tyler, TX15 studi
- Tacoma, WA15 studi
- Chicago, IL15 studi
- San Diego, CA15 studi
- Colorado Springs, CO14 studi
- St. Louis, MO13 studi
- Los Angeles, CA13 studi
- Washington, DC12 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.